Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04339790 · ClinicalTrials.gov registry record

Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers

A clinical trial of Healthy Volunteer and Anxiety Disorder, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
3,655
Enrollment target
1
Study location

NCT04339790: Completed study of Healthy Volunteer and Anxiety Disorder, sponsored by National Institute of Mental Health (NIMH).

NCT04339790 is a study of Healthy Volunteer and Anxiety Disorder that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 3,655 participants, above the 169-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (2063% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04339790, a study of Healthy Volunteer and Anxiety Disorder, has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
3,655 participants
Enrollment target
1
Study location

Study Summary

Background: The COVID-19 outbreak has caused many changes to people s normal social patterns. The respiratory illness has been the major focus of public health efforts. But most experts also agree that government and public health mandates to slow the spread of the illness, such as social distancing, have a significant effect on people s mental health. Environmental stressors, such as constraints on activities, social contact, and access to resources, take a toll. Researchers want to learn how stressors related to COVID-19 affect mental health over time. Objective: To learn the relationship between stressors related to COVID-19 and self-rated measures of mental health symptoms and distress among a range of people. Eligibility: English-speaking adults ages 18 and older Design: This study will be conducted online. Participants will give their first and last name and email address. They will indicate if they have ever been in an NIH research study. They will get a username and password. Every 2 weeks for up to 6 months, participants will complete online study surveys. They will get email reminders. Some surveys will be repeated. At the end of the study, they will complete a set of end-of-study surveys. The surveys will ask about the following: Age, sex, race, and other sociodemographic data Mental and medical illness history and treatment Family medical history Mobility, self-care, and life activities Behaviors related to alcohol and substance use disorder Mental illness symptoms Psychological distress Stressors caused by the COVID-19 pandemic. Participants will get links to mental health resources, such as hotlines. They will also get guidance on steps to take to seek care or support. Study website: nimhcovidstudy.ctss.nih.gov

Primary Outcome

Thoughts and feelings about mental health impact of COVID-19

Study Locations (1)

Maryland

  • National Institute of Mental Health (NIMH) - Bethesda

Trial Details

FieldValue
Enrollment Target 3,655 participants
Start Date 2020-04-07
Est. Completion 2021-06-02

What the finished NCT04339790 record still lists

NCT04339790 is an observational study that tracks outcomes without assigning an intervention. Its 3,655 participants enrollment target places it among the larger protocols in the corpus, above the 169-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (2063% higher).

The record links to 4 conditions, with Healthy Volunteer appearing as the primary indexed condition, and to 0 interventions.

NCT04339790 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04339790 about?

NCT04339790 is a clinical study titled "Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers". Background: The COVID-19 outbreak has caused many changes to people s normal social patterns. The respiratory illness has been the major focus of public health efforts. But most experts also agree that government and public health mandates to slow the spread of the illness, such as social distancin...

What is the current status of trial NCT04339790?

This trial is currently completed. The enrollment target is 3,655 participants. The study started on 2020-04-07. Estimated completion is 2021-06-02.

What conditions does trial NCT04339790 study?

This clinical trial studies the following conditions: Healthy Volunteer, Anxiety Disorder, Mood Disorder, Preexisting Medical Condition.

Who is sponsoring clinical trial NCT04339790?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04339790 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04339790's enrollment target sits among peer trials

3,655 2nd of 112 the highest of 112 other Healthy Volunteer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Volunteer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06702553 · 3,650 participants · Phase 3

    Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass

  • NCT07249398 · 3,650 participants · NA

    Influence of Social Media Ads on Food Choice - Master Protocol

  • NCT06058377 · 3,680 participants · Phase 3

    Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

  • NCT06354920 · 3,624 participants · NA

    M-Well Bonding Bundle to Improve Patient-Physician Relationships

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04339790, the US trial registry maintained by the National Library of Medicine. NCT04339790 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.